Genetiniai ištekliai

UAB ,,Genetiniai ištekliai“ carries out its continuous activities t. y. breeding of promising beef and dairy cattle; seed production of cereals, fiber and oilseeds, experimental, educational and experimental economic activities, protects and breeds gene-stocked Lithuanian black-headed sheep by the closed population method. Created and expands the selection nucleus of Lithuanian local coarse sheep, performs controlled fattening of lambs.
KEY FINANCIAL PERFORMANCE INDICATORS FOR THE PERIOD 2022-2024
- Average annual profitability:
- 2022–2024 ≥ 2,8 percent.
- Annual ratio of total liabilities to equity:
- 2022–2024 limit 0,2–0,3 times
- 2022–2024 limit 0,2–0,3 times
TARGETED SPECIFIC INDICATORS FOR THE PERIOD 2023-2025
- Return on equity ROE,%:
- 2023 – 3,3
- 2024 – 3,57
- 2025 – 4,13
- Level of general and administrative costs, thousand euros:
- 2023 – 225
- 2024 – 230
- 2025 – 235
- Sales revenue, million euros:
- 2023 – 2,4
- 2024 – 2,5
- 2025 – 2,6
- Retention of regular customers, %:
- 2023 – 50
- 2024 – 55
- 2025 – 60
- Employee participation in training, hours:
- 2023 – 20
- 2024 – 24
- 2025 – 28
2022/23 GOOD CORPORATE GOVERNANCE INDEX
2021/22 GOOD CORPORATE GOVERNANCE INDEX
Sk – Transparency dimension
KO – Board dimension
SP – Strategic planning and target achievement dimension
GI – Good governance ratio
Financial results
P/L Statment
2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|
Revenue | 1,750 | 1,890 | 2,471 | 2,750 |
Cost of goods sold | 1,532 | 1,633 | 2,209 | 2,454 |
Gross profit (loss) | 218 | 256 | 262 | 296 |
Gross profit margin | 12% | 14% | 11% | 11% |
Operating expenses | 206 | 199 | 196 | 215 |
Operating profit (loss) | 12 | 58 | 66 | 82 |
Operating profit margin | 1% | 3% | 3% | 3% |
EBITDA | 216 | 197 | 213 | 217 |
EBITDA margin | 12% | 10% | 9% | 8% |
Net profit (loss) | 4 | 44 | 86 | 98 |
Net profit margin | 0% | 2% | 3% | 4% |
2020-06 | 2021-06 | 2022-06 | 2023-06 | |
---|---|---|---|---|
Revenue | 505 | 794 | 976 | 925 |
Cost of goods sold | 473 | 685 | 797 | 1,030 |
Gross profit (loss) | 33 | 109 | 179 | -105 |
Gross profit margin | 6% | 14% | 18% | -11% |
Operating expenses | 101 | 91 | 103 | 122 |
Operating profit (loss) | -69 | 18 | 76 | -228 |
Operating profit margin | -14% | 2% | 8% | -25% |
EBITDA | -6 | 93 | 180 | 129 |
EBITDA margin | -1% | 12% | 18% | 14% |
Net profit (loss) | -71 | 21 | 90 | 46 |
Net profit margin | -14% | 3% | 9% | 5% |
Balance sheet
2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|
Non-current assets | 2,315 | 2,550 | 2,180 | 2,059 |
Intangible assets | 2 | 2 | 1 | 0 |
Tangible assets | 1,865 | 1,945 | 1,758 | 1,636 |
Financial assets | 176 | 313 | 179 | 179 |
Other non-current assets | 273 | 290 | 243 | 245 |
Current assets | 1,143 | 1,032 | 1,183 | 1,398 |
Inventories and prepaid expenses | 686 | 795 | 665 | 882 |
Accounts receivable in one year | 390 | 127 | 349 | 359 |
Other current assets | ||||
Cash and cash equivalents | 67 | 110 | 169 | 158 |
Total assets | 3,468 | 3,600 | 3,381 | 3,474 |
Equity | 2,554 | 2,598 | 2,648 | 2,677 |
Grants and subsidies | 530 | 458 | 390 | 339 |
Liabilities | 384 | 544 | 342 | 459 |
Financial liabilities | 79 | 176 | 139 | 100 |
Long-term liabilities | 5 | 139 | 100 | 60 |
Short-term liabilities | 379 | 405 | 243 | 399 |
Equity and liabilities | 3,468 | 3,600 | 3,381 | 3,474 |
2020-06 | 2021-06 | 2022-06 | 2023-06 | |
---|---|---|---|---|
Non-current assets | 2,517 | 2,503 | 2,132 | 2,232 |
Intangible assets | 2 | 1 | 0 | |
Tangible assets | 2,041 | 1,854 | 1,706 | 1,555 |
Financial assets | 176 | 316 | 179 | 428 |
Other non-current assets | 299 | 332 | 248 | 250 |
Current assets | 1,444 | 1,286 | 1,718 | 1,403 |
Inventories and prepaid expenses | 1,031 | 1,030 | 834 | 961 |
Accounts receivable in one year | 326 | 127 | 608 | 285 |
Other current assets | 0 | 0 | ||
Cash and cash equivalents | 87 | 130 | 276 | 157 |
Total assets | 3,972 | 3,809 | 3,869 | 3,654 |
Equity | 2,483 | 2,579 | 2,669 | 2,635 |
Grants and subsidies | 493 | 423 | 366 | 316 |
Liabilities | 995 | 807 | 835 | 703 |
Financial liabilities | 302 | 158 | 119 | 80 |
Long-term liabilities | 185 | 139 | 100 | 59 |
Short-term liabilities | 811 | 668 | 735 | 643 |
Equity and liabilities | 3,972 | 3,809 | 3,869 | 3,654 |
Financial ratios
2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|
Capital return ratios | ||||
Return on assets (ROA) | 0% | 1% | 2% | 3% |
Return on equity (ROE) | 0% | 2% | 3% | 4% |
Return on capital employed (ROCE) | 0% | 2% | 2% | 3% |
Capital structure and liquidity ratios | ||||
Debt / asset ratio (D/A) | 0.02 | 0.05 | 0.04 | 0.03 |
Current Ratio | 3.02 | 2.54 | 4.88 | 3.50 |
Quick ratio | 1.21 | 0.58 | 2.13 | 1.29 |
Turnover ratios | ||||
Asset turnover | 0.50 | 0.52 | 0.73 | 0.79 |
Fixed asset turnover | 0.76 | 0.74 | 1.13 | 1.34 |
Equity turnover | 0.69 | 0.73 | 0.93 | 1.03 |
Profitability ratios | ||||
EBITDA margin | 12% | 10% | 9% | 8% |
Operating profit margin | 1% | 3% | 3% | 3% |
Net profit margin | 0% | 2% | 3% | 4% |
Other ratios | ||||
Dividends to the State | 0.00 | 35.40 | 69.30 | 87.20 |
Dividends paid / net profit | 0.00 | 0.80 | 0.81 | 0.89 |
2020-06 | 2021-06 | 2022-06 | 2023-06 | |
---|---|---|---|---|
Capital return ratios | ||||
Return on assets (ROA) | 0% | 3% | 4% | 1% |
Return on equity (ROE) | 0% | 5% | 6% | 2% |
Return on capital employed (ROCE) | -3% | 1% | 3% | -8% |
Capital structure and liquidity ratios | ||||
Debt / asset ratio (D/A) | 0.08 | 0.04 | 0.03 | 0.02 |
Current Ratio | 1.78 | 1.92 | 2.34 | 2.18 |
Quick ratio | 0.51 | 0.38 | 1.20 | 0.69 |
Turnover ratios | ||||
Asset turnover | 0.13 | 0.21 | 0.25 | 0.25 |
Fixed asset turnover | 0.20 | 0.32 | 0.46 | 0.41 |
Equity turnover | 0.20 | 0.31 | 0.37 | 0.35 |
Profitability ratios | ||||
EBITDA margin | -1% | 12% | 18% | 14% |
Operating profit margin | -14% | 2% | 8% | -25% |
Net profit margin | -14% | 3% | 9% | 5% |
Other ratios | ||||
Dividends to the State | ||||
Dividends paid / net profit |
Financial statments
Expectations of the state
About the company
- Official nameUAB "Genetiniai ištekliai"
- Legal formPrivate limited liability company (UAB)
- Company code304979983
- SectorOther
- Line of businessHorticulture and animal husbandry
- Institution representing the StateMinistry of Agriculture
- Share belonging to the State100%
Return to the State
87 EUR thousand
ROE
3.7%
Number of employees
60
Financial data provided as at end-December 2022
UAB „Šeduvos avininkystė“ and UAB „Upytės eksperimentinis ūkis“ were reoganized and merged into new company - UAB „Genetiniai ištekliai“, which was registered in the Register of Legal Entities on 2 January 2019.
Management
- Audrius ZalatorisChief Executive Officer
Information as of: 2023/11/03
Board of Directors
CHAIRMAN OF THE BOARD OF DIRECTORS
- Vygantas SliesoraitisUAB Visi namai, UAB Vegta, VšĮ Panovis; Independent member; AB „Kelių priežiūra“; UAB „Pieno tyrimai“; UAB AL holdingas
MEMBERS OF THE BOARD OF DIRECTORS
- Kęstutis ButkusIndependent member; UAB "Ecoservice"; UAB "ITALIANA LT"
- Regina MininienėMinistry of Agriculture
- Virginija ŽoštautienėMinistry of Agriculture
Information as of: 2023/11/03